Status:
NOT_YET_RECRUITING
Efficacy of Lipid-containing Artificial Tears in the Treatment of Dry Eye
Lead Sponsor:
University Hospital Sestre Milosrdnice
Conditions:
Dry Eye Disease
Dry Eye
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical study involves patients with Dry Eye Disease (DED) who are visiting an ophthalmology outpatient clinic. Eligible participants must have an Ocular Surface Disease Index (OSDI) score ≥14 a...
Detailed Description
This clinical trial aims to evaluate the effects of Proluxx artificial tear spray in patients diagnosed with Dry Eye Disease (DED). Participants are recruited from an ophthalmology outpatient clinic a...
Eligibility Criteria
Inclusion
- Ocular Surface Disease Index (OSDI) score between 14 and 50 and at least one positive diagnostic test: tear break-up time (TBUT) \<7 seconds, Schirmer I test (≤10 mm/5 min), or positive corneal staining based on the Oxford grading scheme. In addition, participants must not have used artificial tears for at least two weeks prior to enrollment, even if they were previously on such therapy
Exclusion
- use of systemic or topical corticosteroids, active ocular infection, or ocular surgery within the last 3 months
Key Trial Info
Start Date :
April 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06955585
Start Date
April 25 2025
End Date
September 1 2025
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHC Sestre milosrdnice
Zagreb, City of Zagreb, Croatia, 10000